Induction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase-2 (COX-2)-selective nonsteroidal anti-inflammatory drug: Independence from COX-2 protein expression

Clinical Cancer Research

Volumn 3, Issue 10, 1997, Pages 1679-1683

  Elder, Douglas J E ^a   Halton, Dawn E ^a   Hague, Angela ^a   Paraskeva, Christos ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CYCLOOXYGENASE 2; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN H2; SULINDAC;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CARCINOMA CELL; CELL DEATH; CELL PROLIFERATION; COLORECTAL CARCINOMA; ENZYME INDUCTION; ENZYME INHIBITION; ENZYME SYNTHESIS; EPITHELIUM CELL; HUMAN; HUMAN CELL; INTESTINE EPITHELIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTICARCINOGENIC AGENTS; APOPTOSIS; CELL DIVISION; COLONIC NEOPLASMS; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; HUMANS; ISOENZYMES; MEMBRANE PROTEINS; NEOPLASM PROTEINS; NITROBENZENES; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RECTAL NEOPLASMS; SULFONAMIDES; TUMOR CELLS, CULTURED;

EID: 0030879456     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Giardiello, F. M., Offerhaus, G. J. A., and DuBois, R. N. The role of non-steroidal anti-inflammatory drugs in colorectal cancer prevention. Eur. J. Cancer, 31A: 1071-1076, 1995.
2. Shiff, S. J., Qiao, L., Tsai, L., and Rigas, B. Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cells. J. Clin. Invest., 96: 491-503, 1995.
3. Elder, D. J. E., Hague, A., Hicks, D. J., and Paraskeva, C. Differential growth inhibition by the aspirin metabolite salicylate in human colorectal tumor cell lines: enhanced apoptosis in carcinoma and in vitro-transformed adenoma relative to adenoma cell lines. Cancer Res., 56: 2273-2276, 1996.
4. Pasricha, P. J., Bedi, A., O'Connor, K., Rashid, A., Akhtar, A. J., Zahurak, M. L., Piantadosi, S., Hamilton, S. R., and Giardiello, F. M. The effects of sulindac on colorectal proliferation and apoptosis in familial adenomatous polyposis. Gastroenterology, 109: 994-998, 1995.
5. Trujillo, M. A., Grewal, H. S., and Sampliner, R. E. Non-steroidal antiinflammatory agents in chemoprevention of colorectal cancer. At what cost? Dig. Dis. Sci., 39: 2260-2266, 1994.
6. Masferrer, J. L., Isakson, P. C., and Seibert, K. Cyclooxygenase-2 inhibitors: a new class of anti-inflammatory agents that spare the gastrointestinal tract. In: R. N. DuBois and F. M. Giardiello (eds.), NSAIDs, Eicosanoids, and the Gastroenteric Tract. Gastroenterology Clinics of North America, Vol. 25, pp. 363-372. Philadelphia: Saunders, 1996.
7. Williams, C. S., and DuBois, R. N. Prostaglandin endoperoxide synthase: why two isoforms? Am. J. Physiol., 270: G393-G400, 1996.
8. Tsujii, M., and DuBois, R. N. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2, Cell, 83: 493-501, 1995.
9. Takahashi, M., Fukutake, M., Yokota, S., Ishida, K., Wakabayashi, K., and Sugimura, T. Suppression of azoxymethane-induced aberrant crypt foci in rat colon by nimesulide, a selective inhibitor of cyclooxygenase-2. J. Cancer Res. Clin Oncol., 122: 219-222, 1996.
10. Reddy, B. S., Rao, C. V., and Seibert, K. Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis. Cancer Res., 56: 4566-4569, 1996.
11. Δ716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell, 87: 803-809, 1996.
12. Hanif, R., Pittas, A., Feng, Y., Koutos, M. I., Qiao, L., Staiano-Coico, L., Shiff, S. J., and Rigas, B. Effects of non-steroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway. Biochem. Pharmacol., 52: 237-245, 1996.
13. Alberts, D. S., Hixson, L., Ahnen, D., Bogert, C., Einspahr, J., Paranka, N., Brendel, K., Gross, P. H., Pamukcu, R., and Burt, R. W. Do NSAIDs exert their colon cancer chemoprevention activities through the inhibition of mucosal prostaglandin synthetase? J. Cell. Biochem., 58: 18-23, 1995.
14. Hague, A., Manning, A. M., Hanlon, K. A., Huschtscha, L. I., Hart, D., and Paraskeva, C. Sodium butyrate induces apoptosis in human colonic tumour cell lines in a p53-independent pathway: implications for the possible role of dietary fibre in the prevention of large bowel cancer. Int. J. Cancer, 55: 498-505, 1993.
15. Bracey, T. S., Miller, J. C., Preece, A., and Paraskeva, C. γ-Radiation-induced apoptosis in human colorectal adenoma and carcinoma cell lines can occur in the absence of wild type p53. Oncogene, 10: 2391-2396, 1995.
16. Hague, A. Moorghen, M., Hicks, D., Chapman, M., and Paraskeva, C. BCL-2 expression in human colorectal adenomas and carcinomas. Oncogene, 9: 3367-3370, 1994.
17. Eberhart, C. E., Coffey, R. J., Radhika, A., Giardiello, F. M., Ferrenbach, S., and DuBois, R. N. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology, 107: 1183-1188, 1994.
18. Sano, H., Kawahito, Y., Wilder, R. L., Hashiramoto, A., Mukai, S., Asai, K., Kimura, S., Kato, H., Kondo, M., and Hla, T. Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res., 55: 3785-3789 1995.
19. Kargman, S. L., O'Neill, G. P., Vickers, P. J., Evans, J. F., Mancini, J. A., and Jothy, S. Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer. Cancer Res., 55: 2556-2559, 1995.
20. Kutchera, W., Jones, D. A., Matsunami, N., Groden, J., McIntyre, T. M., Zimmerman, G. A., White, R. L., and Prescott, S. M. Prostaglandin H synthase 2 is expressed abnormally in human colon cancer: evidence for a transcriptional effect. Proc. Natl. Acad. Sci. USA, 93: 4816-4820, 1996.
21. Williams, C. S., Luongo, C., Radhika, A., Zhang, T., Lamps, L. W., Nanney, L. B., Beauchamp, R. D., and DuBois, R. N. Elevated cyclooxygenase-2 levels in Min mouse adenomas. Gastroenterology, 111: 1134-1140.
22. Browne, S. J., Williams, A. C., Hague, A., Butt, A. J., and Paraskeva, C. Loss of APC protein expressed by human colonie epithelial cells and the appearance of a specific low-molecular-weight form is associated with apoptosis in vitro. Int. J. Cancer, 59: 56-64, 1994.
23. Piazza, G. A., Kulchak Rahm, A. L., Krutzsch, M., Sperl, G., Shipp Paranka, N., Gross, P. H., Brendel, K., Burt, R. W., Alberts, D. S., Pamukcu, R., and Ahnen, D. J. Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis. Cancer Res., 55: 3110-3116, 1995.
24. Hayllar, J., and Bjarnason, I. NSAIDs, COX-2 inhibitors, and the gut. Lancet, 346: 521-522, 1995.
25. Futaki, N., Takahashi, S., Yokoyama, I., Higuchi, S., and Otomo, S. NS-398, a new anti-inflammatory agent, selectively inhibits prostag landin G/H synthase/cyclooxygenase (COX-2) activity in vitro. Prostaglandins, 47: 55-59, 1994.
26. Rodrigues, N. R., Rowan, A., Smith, M. E. F., Kerr, I. B., Bodmer, W. F., Gannon, J. V., and Lane, D. P. p53 mutations in colorectal cancer. Proc. Natl. Acad. Sci. USA, 87: 7555-7559, 1990.
27. Williams, A. C., Browne, S. J., Yeudal, W. A., Paterson, I. C., Marshall, C. J., Lane, D. P., and Paraskeva, C. Molecular events including p53 and K-ras alterations in the in vitro progression of a human colorectal adenoma cell line to an adenocarcinoma. Oncogene, 8: 3063-3072, 1993.
28. Elder, D. J. E., and Paraskeva, C. Are aspirin and other non-steroidal anti-inflammatory drugs effective in the prevention and treatment of colorectal cancer? Lancet, 348: 485, 1996.